Weekly vs 3-weekly cisplatin: a retrospective cohort study

被引：0
|
作者：
Saerens, Michael [1 ,2 ]
Van den Broeck, Alexander [2 ]
de Weghe, Geertrui Van [2 ]
Wouter, Huvenne [3 ,4 ]
Peter, Tomassen [3 ,4 ]
Wouter, Bauters [5 ]
Vermassen, Tijl [1 ,2 ]
Sarah, Deschuymer [6 ,7 ]
Rottey, Sylvie [1 ,2 ,8 ]
Duprez, Frederic [6 ,7 ]
机构：
[1] Ghent Univ Hosp, Med Oncol, Ghent, Belgium
[2] Univ Ghent, Basic & Appl Med Sci, Ghent, Belgium
[3] Ghent Univ Hosp, Head & Neck Surg, Ghent, Belgium
[4] Univ Ghent, Head & Skin, Ghent, Belgium
[5] Ghent Univ Hosp, Radiol, Ghent, Belgium
[6] Ghent Univ Hosp, Radiotherapy, Ghent, Belgium
[7] Univ Ghent, Human Struct & Repair, Ghent, Belgium
[8] Ghent Univ Hosp, Drug Res Unit, Ghent, Belgium
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 192卷
关键词：
Chemoradiotherapy; cisplatin; toxicity;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
229
引用
收藏
页码：S280 / S283
页数：5
相关论文
共 50 条
  • [1] Cisplatin Head & Neck Chemoradiotherapy: A Real-World Survival & Compliance Analysis of Weekly vs 3-Weekly Regimes
    Kahan, Jennifer
    Povey, Gail
    Rolles, Martin
    Banner, Russell
    RADIOTHERAPY AND ONCOLOGY, 2024, 192 : S305 - S308
  • [2] 3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck - a multicentre, retrospective analysis
    Helfenstein, Seth
    Riesterer, Oliver
    Meier, Urs R.
    Papachristofilou, Alexandros
    Kasenda, Benjamin
    Pless, Miklos
    Rothschild, Sacha I.
    RADIATION ONCOLOGY, 2019, 14 (1)
  • [3] 3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck – a multicentre, retrospective analysis
    Seth Helfenstein
    Oliver Riesterer
    Urs R. Meier
    Alexandros Papachristofilou
    Benjamin Kasenda
    Miklos Pless
    Sacha I. Rothschild
    Radiation Oncology, 14
  • [4] Locally advanced Head and Neck Tumors among simultaneous Chemoradiotherapy with weekly and 3-weekly Cisplatin Regimens: a retrospective Analysis
    Loeser, A.
    Schodrok, D.
    Trapa, L. Z.
    Matnjani, G.
    Toperim, S.
    Krull, A.
    Petersen, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S130 - S131
  • [5] Weekly or 3-weekly paclitaxel are equally effective
    Peter Sidaway
    Nature Reviews Clinical Oncology, 2016, 13 (5) : 264 - 264
  • [6] Comparison of 3-weekly cisplatin versus 3-weekly carboplatin in patients with locally advanced nasopharyngeal carcinoma (LA-NPC) receiving concurrent chemoradiotherapy (CCRT): A multicenter retrospective study
    Dechaphunkul, A.
    Danchaivijitr, P.
    Jiratrachu, R.
    Dechaphunkul, T.
    Sookthon, C.
    Jiarpinitnun, C.
    Paoin, C.
    Setakornnukul, J.
    Niyomnaitham, S.
    Suktitipat, B.
    Pattaranutaporn, P.
    Ngamphaiboon, N.
    ANNALS OF ONCOLOGY, 2018, 29 : 384 - 384
  • [7] A Multicentre Retrospective Analysis of Toxicity in 6-weekly Versus 3-weekly Pembrolizumab
    Rowe, Michael
    Eastlake, Leonie
    Norris, Timothy
    Farley, Timothy
    Talbot, Toby
    JOURNAL OF IMMUNOTHERAPY, 2021, 44 (04) : 175 - 178
  • [8] 3-weekly or weekly cisplatin concurrently with radiotherapy for patients with locally advanced squamous cell carcinoma of the head and neck: A multicentre, retrospective analysis
    Rothschild, S. I.
    Helfenstein, S.
    Riesterer, O.
    Meier, U. R.
    Papachristofilou, A.
    Kasenda, B.
    Pless, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [9] 3-weekly or weekly cisplatin concurrently with radiotherapy for patients with locally advanced squamous cell carcinoma of the head and neck - A multicentre, retrospective analysis
    Rothschild, S., I
    Helfenstein, S.
    Riesterer, O.
    Meier, U. R.
    Papachristofilou, A.
    Kasenda, B.
    Pless, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 248 - 248
  • [10] 6-Weekly vs 3-Weekly Pembrolizumab - Toxicities and Tolerance in The COVID-era
    Douglas, C.
    Lord, H.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1059 - S1060
12345